Nicotine Levels in Electronic Cigarettes
Reads0
Chats0
TLDR
In ECs, which vaporize nicotine effectively, the amount inhaled from 15 puffs is lower compared with smoking a conventional cigarette, but EC brands and models differ in their efficacy and consistency of nicotine vaporization.Abstract:
Introduction: The electronic cigarette (EC) is a plastic device that imitates conventional cigarettes and was developed to deliver nicotine in a toxin-free vapor. Nicotine in a solution is heated and vaporized when a person puffs through the device and is inhaled as a vapor into the mouth. The EC is a new product on the market and little is known about its safety and nicotine delivery efficacy. The aim of the study was to analyze nicotine levels in vapor generated from various EC brands and models. The study was designed to assess efficacy and consistency of various ECs in converting nicotine to vapor and to analyze dynamics of nicotine vaporization. Methods: Sixteen ECs were selected based on their popularity in the Polish, U.K. and U.S. markets. Vapors were generated using an automatic smoking machine modified to simulate puffing con ditions of real EC users. Nicotine was absorbed in a set of washing bottles with methanol and analyzed with gas chromatography. Results: The total level of nicotine in vapor generated by 20 series of 15 puffs varied from 0.5 to 15.4 mg. Most of the analyzed ECs effectively delivered nicotine during the first 150–180 puffs. On an average, 50%–60% of nicotine from a cartridge was vaporized. Conclusions: ECs generate vapor that contains nicotine, but EC brands and models differ in their efficacy and consistency of nicotine vaporization. In ECs, which vaporize nicotine effectively, the amount inhaled from 15 puffs is lower compared with smoking a conventional cigarette.read more
Citations
More filters
Journal ArticleDOI
Electronic Cigarettes in North America History, Use, and Implications for Smoking Cessation
TL;DR: In this paper, the efficacy and safety of e-cigarettes for smoking cessation were reviewed and issues relevant to the context in which they are used, including product awareness and regulatory and ethical concerns.
Patent
Pulmonary delivery devices
Anant Pandya,George Gallagher +1 more
TL;DR: In this article, a pulmonary delivery apparatus consisting of a first chamber (15) adapted to thermally vaporise a first liquid to form a relatively warm first vapour (B) and a second chamber (16), adapted to atomize a quantity of a second liquid without heating of the second liquid, and an outlet (30) via which, in use, a user can inhale a mixture of the first and second vapours is provided.
Journal ArticleDOI
Trace Metals Derived from Electronic Cigarette (ECIG) Generated Aerosol: Potential Problem of ECIG Devices That Contain Nickel.
TL;DR: The amount of trace metals from ECIG-generated aerosol are lower than in traditional mainstream smoke, and Elemental analysis of the core assembly reveals the presence of several of these trace metals, especially Al, Fe, Ni, and Zn.
Journal ArticleDOI
E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation.
Qixin Wang,Isaac K. Sundar,Dongmei Li,Joseph H. Lucas,Thivanka Muthumalage,Samantha R. McDonough,Irfan Rahman +6 more
TL;DR: Overall, sub-chronic e-cig exposure with or without nicotine affected lung inflammation and repair responses/ECM remodeling, which were mediated by nAChRα7 in a sex-dependent manner.
Journal ArticleDOI
Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS
TL;DR: This pilot study determined TSNA yields in aerosol emitted from HTP in comparison to the electronic and tobacco cigarettes and hypothesised that HTP may be a significant source of tobacco-specific nitrosamines (TSNA).
References
More filters
Journal ArticleDOI
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
TL;DR: The 16 mg Ruyan V8 ENDD alleviated desire to smoke after overnight abstinence, was well tolerated and had a pharmacokinetic profile more like the Nicorette inhalator than a tobacco cigarette.
Journal ArticleDOI
A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects
TL;DR: Under these acute testing conditions, neither of the electronic cigarettes exposed users to measurable levels of nicotine or CO, although both suppressed nicotine/tobacco abstinence symptom ratings and increased product acceptability ratings.
Journal ArticleDOI
Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes?
Zachary Cahn,Michael Siegel +1 more
TL;DR: Electronic cigarettes show tremendous promise in the fight against tobacco-related morbidity and mortality and by dramatically expanding the potential for harm reduction strategies to achieve substantial health gains, they may fundamentally alter the tobacco harm reduction debate.
ARTICLES Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers
TL;DR: The FTC protocol underestimates nicotine and carcinogen doses to smokers and overestimates the proportional benefit of low-yield cigarettes, so FTC-based nicotine medication doses prescribed/recommended for smoking cessation may need to be reassessed.
Journal ArticleDOI
Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers
TL;DR: In this paper, the authors used a pressure transducer system to evaluate puffing characteristics for 133 smokers of cigarettes rated by the FTC at 1.2 mg of nicotine or less.
Related Papers (5)
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy
Jean-François Etter,Chris Bullen +1 more